James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 183 shares at $144.50 ($26K) on 2024-05-29, disclosed to the SEC on 2024-05-30.
Open-market sale of $26k MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |